Discover the Versatility of Copovidone PVP VA64
Your premier choice for pharmaceutical excipients and cosmetic ingredients.
Get a Quote & SampleProduct Core Value
Copovidone PVP VA64
Copovidone PVP VA64 stands out as a high-performance copolymer, widely recognized for its multifaceted applications in both the pharmaceutical and cosmetic industries. Its unique composition as a copolymer of N-vinylpyrrolidone and vinyl acetate (typically in a 60:40 ratio) grants it superior properties that address critical formulation challenges.
- Leverage copovidone PVP VA64 for superior tablet binding in direct compression, ensuring robust and well-formed tablets.
- Utilize this versatile material as a film-forming agent in pharmaceutical coatings, enhancing drug stability and delivery.
- Explore its potential in hot melt extrusion for advanced drug delivery systems, improving the solubility of poorly soluble APIs.
- Benefit from its efficacy as a cosmetic ingredient for hair styling and film formation, offering flexible hold and texture.
Key Advantages
Superior Binding Properties
As a pharmaceutical excipient, Copovidone PVP VA64 provides excellent dry binding capabilities, ideal for direct compression and granulation processes.
Enhanced Formulation Stability
Its role as a film-former contributes to the stability and aesthetic appeal of pharmaceutical coatings and cosmetic products.
Versatile Processing Capabilities
Copovidone is highly suitable for advanced manufacturing techniques such as hot melt extrusion, enabling innovative drug delivery solutions.
Key Applications
Pharmaceutical Tablets
An outstanding tablet binder for direct compression and wet granulation, ensuring optimal tablet hardness and disintegration.
Pharmaceutical Coatings
Functions as an effective film-forming agent, enhancing the performance and appearance of coated pharmaceutical dosage forms.
Cosmetic Formulations
A key ingredient for hair sprays and lotions, acting as a reliable hair-fixing agent with reduced hygroscopicity.
Controlled-Release Systems
Serves as a matrix former in controlled-release formulations, modulating drug release profiles for improved therapeutic outcomes.